Rebecca J Critchley-Thorne
The Tissue Systems Pathology Test Outperforms Pathology Review in Risk Stratifying Patients With Low-Grade Dysplasia.
Khoshiwal A, Frei N, Pouw R, TissueCypher SURF LGD Study Pathologists Consortium, Smolko C, Arora M, Siegel J, Duits L, Critchley-Thorne R, Thangaiah J. The Tissue Systems Pathology Test Outperforms Pathology Review in Risk Stratifying Patients With Low-Grade Dysplasia. Gastroenterology 2023; 165:1168-1179.e6.
Aug 30, 2023The Tissue Systems Pathology Test Outperforms Pathology Review in Risk Stratifying Patients With Low-Grade Dysplasia.
Aug 30, 2023Gastroenterology 2023; 165:1168-1179.e6
Khoshiwal Amir M, Frei Nicola Fabian, Pouw Roos E, TissueCypher SURF LGD Study Pathologists Consortium, Smolko Christian, Arora Meenakshi, Siegel Jennifer J, Duits L C, Critchley-Thorne Rebecca J, Thangaiah Judith Jebastin
An Automated Tissue Systems Pathology Test Can Standardize the Management and Improve Health Outcomes for Patients With Barrett's Esophagus.
Duits L, Khoshiwal A, Frei N, Pouw R, Smolko C, Arora M, Siegel J, Critchley-Thorne R, Thangaiah J, Barrett's SURF LGD Study Pathologists Consortium. An Automated Tissue Systems Pathology Test Can Standardize the Management and Improve Health Outcomes for Patients With Barrett's Esophagus. Am J Gastroenterol 2023; 118:2025-2032.
Jun 13, 2023An Automated Tissue Systems Pathology Test Can Standardize the Management and Improve Health Outcomes for Patients With Barrett's Esophagus.
Jun 13, 2023Am J Gastroenterol 2023; 118:2025-2032
Duits L C, Khoshiwal Amir M, Frei Nicola Fabian, Pouw Roos E, Smolko Christian, Arora Meenakshi, Siegel Jennifer J, Critchley-Thorne Rebecca J, Thangaiah Judith Jebastin, Barrett's SURF LGD Study Pathologists Consortium
Tissue Systems Pathology Test Objectively Risk Stratifies Barrett's Esophagus Patients With Low-Grade Dysplasia
Frei N, Critchley-Thorne R, Meijer S, Seldenrijk K, Ten Kate F, Pouw R, Zhang Y, Stebbins K, Bossart E, Konte K, Khoshiwal A, Bergman J. Tissue Systems Pathology Test Objectively Risk Stratifies Barrett's Esophagus Patients With Low-Grade Dysplasia. Am J Gastroenterol 2021; 116:675-682.
Jan 1, 2021Tissue Systems Pathology Test Objectively Risk Stratifies Barrett's Esophagus Patients With Low-Grade Dysplasia
Jan 1, 2021Am J Gastroenterol 2021; 116:675-682
Frei Nicola Fabian, Critchley-Thorne Rebecca J, Meijer Sybren L, Seldenrijk Kees A, Ten Kate Fiebo J W, Pouw Roos E, Zhang Yi, Stebbins Katelyn, Bossart Emily A, Konte Kadere, Khoshiwal Amir M, Bergman Jacques J G H M
Independent Validation of a Tissue Systems Pathology Assay to Predict Future Progression in Nondysplastic Barrett's Esophagus: A Spatial-Temporal Analysis
Frei N, Konte K, Bossart E, Stebbins K, Zhang Y, Pouw R, Critchley-Thorne R, Bergman J. Independent Validation of a Tissue Systems Pathology Assay to Predict Future Progression in Nondysplastic Barrett's Esophagus: A Spatial-Temporal Analysis. Clin Transl Gastroenterol 2020; 11:e00244.
Jan 1, 2020Independent Validation of a Tissue Systems Pathology Assay to Predict Future Progression in Nondysplastic Barrett's Esophagus: A Spatial-Temporal Analysis
Jan 1, 2020Clin Transl Gastroenterol 2020; 11:e00244
Frei Nicola Fabian, Konte Kadere, Bossart Emily A, Stebbins Katelyn, Zhang Yi, Pouw Roos E, Critchley-Thorne Rebecca J, Bergman Jacques J G H M